Severe Superior Vena Cava Syndrome in a Patient With Metastatic Melanoma Receiving Nivolumab: A Case Report
Immune checkpoint inhibitors (ICIs) such as nivolumab have revolutionized cancer therapy, including melanoma. Immune-related events happen in up to 70% of patients. Sarcoid-like reactions are rare and can mimic tumor progression. An 82-year-old man with metastatic melanoma receiving nivolumab for 5...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
American College of Physicians
2025-02-01
|
| Series: | Annals of Internal Medicine: Clinical Cases |
| Online Access: | https://www.acpjournals.org/doi/10.7326/aimcc.2024.0851 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|